About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Diabetes Clinical Trials in Philadelphia | 7 Studies

Clinical Trials DiabetesPhiladelphia

Diabetes Clinical Trials in Philadelphia

Find 7 clinical trials for diabetes near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Diabetes trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-7 of 7 trials

CompletedPharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes MellitusThe purpose of this study is to determine the pharmacokinetic and safety profile of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus.NCT00957268·Miami, Florida and 6 others CompletedAffects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic GastroparesisThe purpose of this study is to test the safety and effectiveness of two dosage levels (10mg and 20mg) of TZP-102 compared to placebo (capsule that looks like the study drug but…NCT01452815·Huntsville, Alabama and 51 others

Diabetes Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedAfrezza® INHALE-1 Study in PediatricsINHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e., the Afrezza group) versus…NCT04974528·Los Angeles, California and 38 others

CompletedClinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusThis open-label, multicenter study is designed to investigate the clinical utility and safety of pramlintide treatment in subjects with type 1 and type 2 diabetes who are failing…NCT00108004·Anaheim, California and 47 others

WithdrawnSYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 DiabetesThe purpose of this study is to find out how well a new continuous glucose monitor works for people with diabetes.NCT06719531·Birmingham, Alabama and 27 others

TerminatedSafety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaThis trial is conducted in Europe, Asia, Oceania and the United States of America (USA).NCT00523042·Fresno, California and 31 others

SuspendedEvaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 DiabetesThe Revita® system is being investigated to assess the efficacy of DMR versus Sham on improvement in Glycemic, Hepatic and Cardiovascular endpoints for patients with Type 2…NCT04419779·Phoenix, Arizona and 57 others

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia